| Roja Chimakurthi, MD | |
|
200 Medical Center Dr, Ste 360, Middletown, OH 45005-5200 | |
| (513) 217-5720 | |
| (513) 217-5729 |
| Full Name | Roja Chimakurthi |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 21 Years |
| Location | 200 Medical Center Dr, Middletown, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679730162 | NPI | - | NPPES |
| 037560800 | Medicaid | MD | |
| 974970-01 | Other | MD | CAREFIRST BC/BS |
| S062-0440 | Other | MD | CAREFIRST BC/BS - REGIONAL |
| PENDING | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 35.129555 (Ohio) | Primary |
| 207RN0300X | Internal Medicine - Nephrology | 49460 (Kentucky) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Davita - West Hamilton Dialysis | Hamilton, OH | Dialysis facility |
| Davita - Butler County Dialysis | Franklin, OH | Dialysis facility |
| Davita - Atrium | Middletown, OH | Dialysis facility |
| Atrium Medical Center | Franklin, OH | Hospital |
| Mercy Health - Fairfield Hospital | Fairfield, OH | Hospital |
| Bethesda North | Cincinnati, OH | Hospital |
| West Chester Hospital | West chester, OH | Hospital |
| Fort Hamilton Hughes Memorial Hospital | Hamilton, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kidney And Hypertension Center Inc | 9830099985 | 46 |
| Kidney And Hypertension Center Inc | 9830099985 | 46 |
News Archive
Medtronic, Inc. today announced the global launch of a new tricuspid ring for the treatment of tricuspid valve disease. Called the Contour 3D™ Annuloplasty Ring, the device is designed to restore normal valve function by remodeling the natural valve's shape and size. The Contour 3D Ring is approved for use in the U.S., Europe and several other countries.
Array BioPharma today announced that ARRY-797 met its primary endpoint in a randomized, placebo-controlled and active-controlled (oxycodone ER) Phase 2 clinical trial in 157 osteoarthritis patients suffering from moderate to severe knee pain despite the use of non-steroidal anti-inflammatory drugs (NSAIDs).
Medtronic, Inc. announced today pivotal data for the Medtronic Arctic Front® CryoAblation Catheter System will be presented as a late breaking clinical trial at the 59th Annual Scientific Session of the American College of Cardiology on Monday, March 15 at 8 a.m. ET. The STOP-AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial is evaluating the safety and efficacy of the Arctic Front CryoAblation Catheter System for paroxysmal atrial fibrillation (AF) patients.
Marijuana may bring on temporary paranoia and other psychosis-related effects in individuals at high risk of developing a psychotic disorder, finds a preliminary study from researchers at Columbia University Medical Center.
› Verified 7 days ago
| Entity Name | Kidney And Hypertension Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306944871 PECOS PAC ID: 9830099985 Enrollment ID: O20040113000581 |
News Archive
Medtronic, Inc. today announced the global launch of a new tricuspid ring for the treatment of tricuspid valve disease. Called the Contour 3D™ Annuloplasty Ring, the device is designed to restore normal valve function by remodeling the natural valve's shape and size. The Contour 3D Ring is approved for use in the U.S., Europe and several other countries.
Array BioPharma today announced that ARRY-797 met its primary endpoint in a randomized, placebo-controlled and active-controlled (oxycodone ER) Phase 2 clinical trial in 157 osteoarthritis patients suffering from moderate to severe knee pain despite the use of non-steroidal anti-inflammatory drugs (NSAIDs).
Medtronic, Inc. announced today pivotal data for the Medtronic Arctic Front® CryoAblation Catheter System will be presented as a late breaking clinical trial at the 59th Annual Scientific Session of the American College of Cardiology on Monday, March 15 at 8 a.m. ET. The STOP-AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial is evaluating the safety and efficacy of the Arctic Front CryoAblation Catheter System for paroxysmal atrial fibrillation (AF) patients.
Marijuana may bring on temporary paranoia and other psychosis-related effects in individuals at high risk of developing a psychotic disorder, finds a preliminary study from researchers at Columbia University Medical Center.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Roja Chimakurthi, MD 4600 Montgomery Rd, Ste 105, Cincinnati, OH 45212-2697 Ph: (513) 487-5305 | Roja Chimakurthi, MD 200 Medical Center Dr, Ste 360, Middletown, OH 45005-5200 Ph: (513) 217-5720 |
News Archive
Medtronic, Inc. today announced the global launch of a new tricuspid ring for the treatment of tricuspid valve disease. Called the Contour 3D™ Annuloplasty Ring, the device is designed to restore normal valve function by remodeling the natural valve's shape and size. The Contour 3D Ring is approved for use in the U.S., Europe and several other countries.
Array BioPharma today announced that ARRY-797 met its primary endpoint in a randomized, placebo-controlled and active-controlled (oxycodone ER) Phase 2 clinical trial in 157 osteoarthritis patients suffering from moderate to severe knee pain despite the use of non-steroidal anti-inflammatory drugs (NSAIDs).
Medtronic, Inc. announced today pivotal data for the Medtronic Arctic Front® CryoAblation Catheter System will be presented as a late breaking clinical trial at the 59th Annual Scientific Session of the American College of Cardiology on Monday, March 15 at 8 a.m. ET. The STOP-AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial is evaluating the safety and efficacy of the Arctic Front CryoAblation Catheter System for paroxysmal atrial fibrillation (AF) patients.
Marijuana may bring on temporary paranoia and other psychosis-related effects in individuals at high risk of developing a psychotic disorder, finds a preliminary study from researchers at Columbia University Medical Center.
› Verified 7 days ago
Dr. Clifford Quinn Cabansag, MD Nephrology Medicare: Medicare Enrolled Practice Location: 4302 Roosevelt Blvd, Middletown, OH 45044 Phone: 513-433-1032 Fax: 513-433-1245 | |
Lotfi F Mamlouk, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 6730 Roosevelt Ave Ste 303, Middletown, OH 45005 Phone: 513-874-0486 Fax: 513-280-8868 | |
Ali Usmani, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 103 Mcknight Dr, Suite A, Middletown, OH 45044 Phone: 513-217-6400 Fax: 513-217-6037 | |
Scott Lawrence Zollett, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 200 Medical Center Dr, Suite 490, Middletown, OH 45005 Phone: 513-424-1291 Fax: 513-424-9422 | |
Stephen Houff, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 105 Mcknight Dr, Middletown, OH 45044 Phone: 330-493-4443 Fax: 330-493-8677 | |
Stephen R Moore, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1040 Summitt Sq, Middletown, OH 45042 Phone: 513-425-0533 Fax: 513-425-0527 | |
Gary C Brown, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 103 Mcknight Dr, Suite A, Middletown, OH 45044 Phone: 513-217-6400 Fax: 513-217-6037 |